When to use first-generation anti-obesity medications: Mechanisms, clinical indications, and patient-focused selection

Bartolome Burguera, Marcio L. Griebeler, Dua Al-Husni

Open source

DOI
10.1016/bs.apha.2026.09.003
Published
2026
Container
Advances in Pharmacology
Publisher
Elsevier
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/bs.apha.2026.09.003,
  title = {When to use first-generation anti-obesity medications: Mechanisms, clinical indications, and patient-focused selection},
  author = {Bartolome Burguera and Marcio L. Griebeler and Dua Al-Husni},
  year = {2026},
  journal = {Advances in Pharmacology},
  doi = {10.1016/bs.apha.2026.09.003},
  url = {https://doi.org/10.1016/bs.apha.2026.09.003}
}

RIS

TY  - JOUR
TI  - When to use first-generation anti-obesity medications: Mechanisms, clinical indications, and patient-focused selection
AU  - Bartolome Burguera
AU  - Marcio L. Griebeler
AU  - Dua Al-Husni
PY  - 2026
JO  - Advances in Pharmacology
DO  - 10.1016/bs.apha.2026.09.003
UR  - https://doi.org/10.1016/bs.apha.2026.09.003
ER  - 

APA

Burguera, B., Griebeler, M. L., & Al-Husni, D. (2026). When to use first-generation anti-obesity medications: Mechanisms, clinical indications, and patient-focused selection. Advances in Pharmacology. https://doi.org/10.1016/bs.apha.2026.09.003

Source records